Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P43146 (tumour suppressor)
 5,935 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Tumours of the gastrointestinal (GI) tract, of which 70% arise in the colorectum, are a major cause of morbidity and mortality worldwide. Transformation from normal to malignant mucosa is a multistep process involving specific gene mutations and is called the adenoma-carcinoma sequence. Histologically, adenomas are of three types (tubular, tubulovillous and villous) and the extent of mucosal cellular abnormality of three grades (mild, moderate and severe). Cellular proliferation is a marker of malignant potential in many tissues. In the colon, cellular proliferation is partly controlled by the CDX-2 gene, a homeobox gene expressed in differentiated cells of the intestine that has proto-oncogenic potential in murine models. In the stomach, CDX-2 is expressed in intestinal metaplasia and decreasing expression through tumourogenesis shows its tumour suppressor potential. Down-regulation in colorectal cancer cell lines is also observed. This is a retrospective study of colorectal adenomas, and haematoxylin and eosin (H&E) and immunocytochemical staining for CDX-2 and MIB-1 (a cell proliferation marker) are performed on each case. Comment is made on the morphological features (adenoma type and dysplasia severity) and the grade of CDX-2 and MIB-1 expression. This study showed that dysplasia severity is linked to cellular proliferation (P=0.011) but adenoma type was not (P=0.54). CDX-2 was not linked to the morphological features discussed (P=0.11 and P=0.16) and CDX-2 and MIB-1 expression showed no correlation. Increased cell proliferation (MIB-1 expression) was seen in increasingly dysplastic adenomatous lesions of the colorectum. CDX-2 had no link to morphological features or cell proliferation of the dysplastic mucosa.
 ...
PMID:CDX-2 and MIB-1 expression in the colorectum: correlation with morphological features of adenomatous lesions. 1687 98